Patents by Inventor Jorge Luis Martinez Torrecuadrada

Jorge Luis Martinez Torrecuadrada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTERLEUKIN 11 RECEPTOR ALPHA SUBUNIT (IL11RA) NEUTRALIZING ANTIBODIES AND USES THEREOF
    Publication number: 20240287197
    Abstract: The present invention relates to neutralizing antibodies which specifically recognize the interleukin 11 receptor alpha subunit (IL11RA) extracellular domain and to antibody drug conjugates (ADCs) comprising a therapeutic agent and said neutralizing antibodies. The invention also relates to a method for detecting the IL-11 receptor, to pharmaceutical compositions and to the use of said antibodies or ADCs in the treatment of diseases characterized by an increased IL11RA signaling.
    Type: Application
    Filed: July 14, 2021
    Publication date: August 29, 2024
    Inventors: Laura OJEDA MÁRQUEZ, Irene FERRER SÁNCHEZ, Luis PAZ-ARES RODRÍGUEZ, Jorge Luis MARTÍNEZ TORRECUADRADA, Giovanna RONCADOR
  • Anti-ephrin-B2 antibody and compositions comprising it
    Patent number: 9062109
    Abstract: The present invention relates to a novel antibody against ephrin B2 and its use to detect the protein and as a medicament for inhibiting angiogenesis and lymphangiogenesis in the treatment of diseases in which these processes are implicated, for example, cancer.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: June 23, 2015
    Assignee: Fundacion Centro Nacional De Investigaciones Oncologicas (CNIO)
    Inventors: Jorge Luis Martinez Torrecuadrada, Maria Angeles Abengozar Infantes
  • ANTI-EPHRIN-B2 ANTIBODY AND USE THEREOF
    Publication number: 20130287795
    Abstract: The present invention relates to a novel antibody against ephrin B2 and its use to detect the protein and as a medicament for inhibiting angiogenesis and lymphangiogenesis in the treatment of diseases in which these processes are implicated, for example, cancer.
    Type: Application
    Filed: September 20, 2011
    Publication date: October 31, 2013
    Applicant: FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS
    Inventors: Jorge Luis Martinez Torrecuadrada, Maria Angeles Abengozar Infantes